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Abstract
The potential of contrast-enhanced cardiovascular magnetic resonance (CMR) for a quantitative assessment of myo-
cardial perfusion has been explored for more than a decade now, with encouraging results from comparisons with
accepted “gold standards”, such as microspheres used in the physiology laboratory. This has generated an increas-
ing interest in the requirements and methodological approaches for the non-invasive quantification of myocardial
blood flow by CMR. This review provides a synopsis of the current status of the field, and introduces the reader to
the technical aspects of perfusion quantification by CMR. The field has reached a stage, where quantification of
myocardial perfusion is no longer a claim exclusive to nuclear imaging techniques. CMR may in fact offer impor-
tant advantages like the absence of ionizing radiation, high spatial resolution, and an unmatched versatility to
combine the interrogation of the perfusion status with a comprehensive tissue characterization. Further progress
will depend on successful dissemination of the techniques for perfusion quantification among the CMR
community.
Introduction
The title of this review, “perfusion quantification” refers to
the approaches used with cardiovascular magnetic reso-
nance (CMR) to assess or measure myocardial blood flow
from the contrast enhancement observed during the first
pass of a contrast agent bolus. This technique is often
referred to by the name of “first pass” imaging, because
the first pass of a contrast agent represents the phase of
contrast enhancement most sensitive to changes in blood
flow, be it from disease, pharmacological intervention, or
exercise. Another approach, not requiring exogenous con-
trast, and referred to as arterial spin labeling, can also be
employed to assess myocardial blood flow [1]. Although a
promising technique that is not burdened by concerns
about contrast administration in patients with poor renal
function, it still remains largely confined to experimental
studies, challenged by poor contrast-to-noise, and arguably
only practically relevant for cardiac studies at 3 Tesla, or
higher field strengths. Another promising technique for
assessing myocardial perfusion is based on blood-oxygen-
level dependent (BOLD) myocardial imaging [2,3]. This
type of endogeneous contrast mechanism is dependent on
a combination of factors such as blood flow, but also
oxygen extraction fraction, with the latter normally declin-
ing with increasing myocardial blood flow [4]. BOLD ima-
ging does not provide as direct an assessment of
myocardial blood flow, as contrast-enhanced perfusion
imaging. This review will focus on the quantification of
myocardial perfusion by the use of contrast-enhanced
techniques, which in the future may include novel contrast
agents such as hyper-polarized media [5], but at the pre-
sent time is mostly performed by the administration of
gadolinium chelates as contrast agent. For the purpose of
this review article, we define the quantification of myocar-
dial perfusion as methods or approaches to determine the
tissue blood flow in the heart muscle. A recent compre-
hensive review with considerable detail on the technical
aspects of myocardial perfusion imaging can be found
in [6].
The quest to quantify myocardial perfusion has been
largely motivated by the desire to obtain quantitative,
observer-independent, and reproducible measures of the
myocardial perfusion status. Whether a quantitative
approach improves the accuracy of myocardial perfusion
imaging, such as for the detection of coronary artery dis-
ease, remains controversial, with circumstantial evidence
pointing to the benefits of a quantitative analysis, versus
a qualitative interpretation in cases of multi-vessel dis-
ease. But in the research realm, there is by now a long
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cardial perfusion leads to new insights in coronary phy-
siology and the etiology of cardiac diseases.
CMR Acquisition Methods
In the context of perfusion quantification, there are two
aspects of myocardial perfusion studies that warrant some
discussion about the methods for dynamic image acquisi-
tion. First of all, one assumes that the observed contrast
enhancement is proportional to the change of contrast
concentration in the tissue. For example, if one were to
use a pulse sequence giving mixed T1/T2* contrast, with
T1 effects prevailing at lower contrast concentrations, and
T2* effects dominating at higher concentrations, then this
would give rise to signal increases at lower concentrations,
which would be confounded by signal loss at higher con-
centrations. It is preferable to have a sequence technique
that makes one contrast mechanism (e.g. T1) prevail. T1-
weighted imaging is predominantly used for myocardial
perfusions studies, not the least because the vascular
volume and also the distribution volume of Gd-chelates is
sufficiently large to yield appreciable signal intensity
changes in myocardial tissue. The short echo times inher-
ent in weighting the signal towards T1 are advantageous
for minimizing the effects of myocardial motion and flow,
as one would otherwise have increasing signal attenuation
due to motion and flow when the echo time (TE) becomes
longer.
A second aspect relates to the nature of contrast
enhancement in the blood pool of the ventricular cavity
or the proximal aorta. Intuitively, it is obvious that myo-
cardial contrast enhancement is driven by arterial
enhancement. In fact, we will see that the myocardial
contrast enhancement can be considered as a linear
response to the arterial contrast enhancement, which
implies that myocardial contrast enhancement can never
proceed at a rate faster than for the arterial contrast
enhancement. For this reason it is important to measure
the contrast enhancement in the blood pool as reference
for the analysis of the myocardial contrast enhancement.
Ideally, the arterial contrast enhancement would be mea-
sured as close as possible to the myocardial region under
consideration, but in practice one can only expect to
measure enhancement in the blood pool at a location in
the left ventricle, or in the proximal aorta. Either way, the
pulse sequence should not be overly sensitive to blood
flow in the great vessels or the ventricular cavities, nor
should it suppress the signal from flowing blood. For
example, pulse sequences with long echo-trains after
each radio-frequency excitation would suppress signal
from blood flow in the ventricular cavities and should be
avoided for quantitative perfusion studies.
The contrast enhancement in the blood pool has a non-
linear or sub-linear dependence on contrast concentration,
with the nonlinearity, or contrast-enhancement saturation,
becoming more pronounced as contrast concentration
increases [7,8]. Eventually, the signal intensity would even
start to decrease above a certain contrast level, due to T2*
effects. Signal saturation effects need to be avoided or cor-
rected, if one wants to accurately measure the arterial
input of contrast. Methods for quantifying myocardial per-
fusion use the arterial input as reference. Any systematic
underestimate of arterial contrast enhancement results in
an overestimate of myocardial perfusion, i.e. relative to the
arterial contrast enhancement, myocardial contrast
enhancement appears to be higher than is truly the case,
and assuming negligible myocardial signal saturation.
Possible solutions to avoid arterial signal saturation are:
a) the use of lower contrast dosages, which avoid the
saturation effect, albeit at the price of reduced contrast-
to-noise in the myocardium; b) employing dual contrast
sequences [8,9]; c) using a dual contrast bolus protocol
[10], and d) correcting retrospectively for signal satura-
tion, e.g. by using calibration curves [11,12] (see section
below on Signal Intensity and Contrast Concentration).
Briefly, the dual-contrast sequences include low-resolu-
tion dynamic imaging of the enhancement in the ventri-
cular cavity, in addition to high(er) resolution imaging of
myocardial enhancement. With a 2D dual-contrast
sequence one images several slices (e.g. in short axis
view) during a heart beat to capture the myocardial con-
trast enhancement with strong T1 weighting, and during
the same heart beat also acquires a low resolution image
of the contrast enhancement in the ventricular cavity,
with lower T1-weighting than for the myocardium, to
avoid saturation at higher contrast concentrations. The
low resolution blood pool image has a low T1 weighting,
because fewer phase-encodings are carried out between
magnetization preparation and read-out of central phase-
encodings, resulting in a shorter delay after inversion
(TI) or saturation. The short delay, and resulting low-T1
weighting, improves the linearity of the signal-intensity
vs. R1 relationship at higher contrast concentrations.
The dual bolus approach involves giving a low dosage
contrast bolus to characterize the arterial input of con-
trast, followed by a higher dosage bolus to image the
myocardial contrast enhancement. The two bolus
dosages are in a pre-determined ratio (e.g. 1:10) that is
then used to scale the arterial input function (AIF) from
the low-dosage bolus to analyze the myocardial contrast
enhancement with the rescaled and time-shifted AIF.
A further important aspect is the administration of
contrast: If the contrast is injected slowly, then the
observed myocardial contrast enhancement is bottle-
necked by the slow arterial enhancement, and myocar-
dial enhancement becomes relatively insensitive to
blood flow. To achieve good sensitivity to myocardial
blood flow, the contrast agent should be injected as a
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particular for measurements of the hyperemic response.
In other words, as the blood flow increases, the require-
ment for a bolus injection become more demanding,
while for resting flows, injection rates as low as 1 ml/s
are acceptable. There is no stringent reason why the
injection rates for rest and hyperemic flow measure-
ments need to be the same, although in practice this is
generally the case.
The signal-intensity-based analysis of myocardial per-
fusion can be confounded by spatial variation of the coil
sensitivity profiles, e.g. with phased-array receive coils,
and also by B1 inhomogeneity effects, e.g. due to dielec-
tric effects, in particular at magnetic field strengths of 3
Tesla or higher. Body RF coils, used almost exclusively
for RF excitation, are designed to achieve excellent B1
homogeneity, albeit under assumed ideal conditions. B1
inhomogeneity over a region with the dimensions of the
heart can be brought about by two conditions: a) the
electromagnetic wavelength of the RF excitation can
approach the field of view dimensions at higher field
strengths, and in tissue the wavelength can be even
shorter, because tissue has a comparatively high relative
dielectric constant or permittivity (e.g. εr~70 at 100
MHz for muscle tissue); and b) the dielectric properties
within the anatomical region being imaged can be highly
heterogeneous, thereby giving rise to dielectric reso-
nances, a form of constructive B1 interference effects
that can be set up in a dielectric “cavity”.B 1 inhomo-
geneity can contribute to signal intensity variation over
the heart, but equally important, it also causes unin-
tended changes for the magnetization preparation. For
the latter, it is useful to realize that a magnetization pre-
paration with a nominal inversion pulse that deviates
from the ideal 180° flip angle can be confounded with a
more rapid relaxation recovery, and similar observations
apply to saturation pulses. In other words, in the pre-
sence of B1 inhomogeneity, the signal intensity varia-
tions can mimic perfusion defects. Currently, the most
common solution for myocardial perfusion imaging at ≥
3 T ,i st h eu s eo fa d i a b a t i c ,i . e .B 1-insensitive, RF inver-
sion or saturation pulses, or composite pulses. Adiabatic
pulses increase the SAR burden, because the B1 ampli-
tude intrinsically has to be considerably higher than
normal (to meet the adiabaticity condition), and the
pulses also have 5 to 10-fold longer durations, both of
which increase the deposited RF energy (proportional to
B1
2·Δt, over a time interval Δt of the pulse, during
which B1 is approximately constant). Composite pulses
represent a practical compromise with lower SAR bur-
den than adiabatic pulses, but they still compensate for
B1 inhomogeneity or flip-angle variation [14].
The spatial variation of receive coil sensitivity, although
also a potential source of misinterpretation of contrast
enhancement, can be corrected for in practice by map-
ping out, or estimating the coil sensitivy profile(s). Map-
ping of the coil sensitivity profiles is a prerequisite for
reconstruction of images acquired with parallel imaging
acceleration, which intrinsically also takes care of the
coil-sensitivity variation in the reconstructed images.
Otherwise, coil sensitivity has to be estimated from one
of the pre-contrast images, and preferably images
acquired with proton-density weighting, and insensitive
to in-flow in the ventricular cavity (“bright blood effect”).
Recent implementations of myocardial perfusion
sequences include such proton-density acquisitions as
the first 1-2 images in a dynamic imaging scan, by leaving
out the magnetization preparation, and using a small flip-
angle for the image read-out [15]. To reduce the impact
of noise, the data of different myocardial segments within
one slice can be fitted to a sinusoidal function [15].
A sinusoidal variation would be a first-order approxima-
tion, assuming a locally linear spatial variation of the sig-
nal intensity, and a circular short axis cross-section of
the left ventricle (LV). A common way to correct for
intrinsic, spatial signal intensity variations is to divide the
myocardial signal by its pre-contrast value. This corrects
for variations for the signal within the myocardium, due
to receive-coil inhomogeneity, but for the blood pool a
similar correction is only feasible if pre-contrast-signal is
not enhanced by flow, and predominantly proton-density
weighted. It is also implicitly assumed that the proton
density of myocardium and blood are about the same.
Pulse Sequence Techniques and Perfusion
Quantification
Techniques for image acquisition in myocardial perfusion
studies have spanned, in approximate order of image
acquisition speed, the range from (spoiled) gradient echo
imaging with cartesian, or radial [16] k-space trajectories,
through gradient echo imaging with steady state free pre-
cession [17,18], to echo-planar [19-22], and spiral techni-
ques [23]. The spoiled gradient-echo technique is
the slowest, but least susceptible to artifacts from off-
resonance shifts (i.e. field inhomogeneities), T2* and sus-
ceptibility effects, and flow and motion. Compared to an
acquisition with steady state free precession, the spoiled
gradient echo technique suffers from nearly two-times
lower signal-to-noise [17], but steady-state free preces-
sion techniques are currently not a viable option for per-
fusion imaging at 3 Tesla or higher field strengths,
because of image artifacts. Echo-planar techniques are
mostly used in a hybrid form, where the echo-train
length is limited to approximately 3-6 echoes, depending
on field strength and T2*. Similarly, the spiral technique
is not used in a single-shot read-out mode for contrast-
enhanced myocardial perfusion imaging, but instead
interleaved spirals are acquired to reduce the effective
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que is suitable for quantitative myocardial perfusion ima-
ging depends on details of its implementation on any
particular scanner platform, field strength, and contrast
agent. It is conceivable that a particular technique may
work with a standard gadolinium-chelate, but that with a
iron-based contrast agent, T2* effects cause too much
susceptibility artifacts.
Signal Intensity and Contrast Concentration
The quantitative assessment of myocardial perfusion
relies on measuring the rate at which tracer (i.e. contrast
agent in the case of “first pass” perfusion studies) arrives
in a tissue region of interest. The tracer concentration in
tissue is detected indirectly by the T1 effect of the con-
t r a s to nt h e1 Hs i g n a l .T 1i nah o m o g e n e o u sv o x e l( i . e .
without compartmentalization) is directly proportional to
the contrast concentration, and the proportionality con-
stant is the T1-relaxivity of the contrast agent (r1):
RR r G d n 111 =+ ⋅ [] , (1)
where R1n denotes the native T1 relaxation rate con-
stant (i.e. in the absence of any contrast agent) and
[Gd], the concentration of Gd contrast in the voxel. The
relaxivity of most Gd-chelate agents is unchanged as it
transitions from blood into tissue, with albumin-binding
agents being one notable exception.
Any pulse sequence yields a finite dynamic range for
signal changes when contrast is introduced, with a theo-
retical upper bound set by the proton density. We give
here a specific example for a spoiled gradient echo
sequence, with saturation recovery magnetization pre-
paration, and linear ordering of the phase-encodings.
After N/2 phase-encoding steps (i.e. the number of
phase-encodings to reach the central k-space line) the
signal intensity is given by [24]:
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where S0 is the equilibrium signal, TR the repetition
time per phase encoding, R1 the T1 relaxation rate (R1
=1 / T 1 ), TD, the delay between magnetization prepara-
tion and start of FLASH read-out, E=e x p ( - R 1 · T R ) ,a n d
a=E · c o s ( a),w i t ha denoting the flip angle. The signal
intensity of the central-k-space echoes determines the
overall contrast characteristics of an image, although
contrast enhancement in smaller structures, is also
weighted by the T1-weighting of higher-frequency k-
space echoes. The effects of the modulation of the
phase-encoding amplitudes by an inversion, or satura-
tion recovery have not been systematically investigated,
but could impact negatively on the quantification of
blood flow, e.g. in thinned LV walls.
The expression in [2], plotted in Figure 1 as function
of the relaxation R1, shows a linear dependence of the
signal intensity at low R1 values (long T1’s), and then
takes on a convex shape at higher R1 values. The devia-
tion from the linear extrapolation for short R1’si sm o s t
apparent with longer times between magnetization pre-
paration (saturation pulse) and read-out of the central
k-space line. Ideally, one would want the signal intensity
to have a linear dependence on R1, as shown by the
grey, dashed-line extrapolations in Figure 1. To first
approximation, this can be achieved by using lower con-
trast dosages (< 0.05 mmol/kg at 1.5 T with Gd-DTPA).
Any deviation from a linear dependence of the signal on
R1, or tracer concentration, will be most apparent in the
blood pool of the LV cavity or the aorta, where one
measures the arterial input: downstream from the arter-
ial input the contrast bolus becomes more dispersed,
Figure 1 Function of the relaxation R1. The signal intensity of the
central k-space lines, which determines the overall image contrast,
was calculated for a rapid gradient echo sequence (TR = 2 ms, flip
angle = 15°) with magnetization preparation and linear phase-
encoding order as a function of R1. The red line is for the case where
the temporal separation (TI) between saturation pulse and the central
k-space line equals 130 ms, corresponding to a total of 128 phase
encoding steps. The blue curve corresponds to a low-resolution
image with 45 phase-encoding steps. The signal intensity initially
shows a linear dependence on R1, which starts to show a convex
shape for higher R1 values. This deviation from the linear
dependence is referred to as signal saturation. The initial linear
dependence of SI on R1 was extrapolated to larger R1 values, and
represents the ideal case for a quantitative perfusion analysis, where
signal intensity in blood is linearly proportional to contrast
concentration. For the shorter TI, the linear regime extends to higher
R1 values, than with a longer TI. A short TI setting is therefore
preferable to avoid signal saturation (e.g. in the blood pool).
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lower. The fact that the observed peak signal intensity
in tissue is much lower than in the blood pool does not
imply that there is no signal saturation in the tissue. It
simply reflects the fact that the distribution volume in
tissue is < ~30%, but the signal intensity contribution
from the vascular space could very well suffer from
saturation effects. The attention for correction of satura-
tion effects has nevertheless focused primarily on the
signal in the blood pool, in good part because it is read-
ily discernible when the peak of the bolus is flattened by
saturation, and also because there exist approaches to
correct for saturation. Signal saturation for the vascular
component of the signal in tissue has not been
addressed much in the literature, arguably because it
represents a more complex challenge.
With pre-contrast T1 measurements, knowledge of the
sequence parameters, and numerical simulation, it is
possible to correct the signal saturation, by generating
calibration curves to replace the measured signal inten-
sity, or percent contrast enhancement, by their corre-
sponding values in the absence of signal saturation
[11,12]. Alternatively, one can measure the signal inten-
sity calibration curves, but this turns into a more
tedious approach, and with a change of sequence para-
meters it may be necessary to regenerate a calibration
curve. Details on methods for saturation correction can
be found in [11,12]. If the saturation effect is neglected,
then the contrast enhancement in the myocardium will
appear to be larger relative to the arterial contrast
enhancement, and myocardial perfusion is overesti-
m a t e d .T h eo v e r e s t i m a t eo fb l o o df l o wc a nb ea l m o s t
proportional to the peak saturation effect, i.e. a 30%
reduction of the peak signal intensity of the arterial
input due to saturation can cause an overestimate of
myocardial blood flow of similar relative magnitude.
Signal Intensity Artifacts
Although it may go without saying that signal intensity
curves for myocardial regions of interest should represent
only the underlying tissue properties, this may be difficult
to achieve for the endocardial layer, because the regional
signal intensity average may include an admixture from
the ventricular blood pool. Several factors can contribute
to this, all too often, subtle artifact: the endocardial bor-
der definition may be poor, which can lead to the inad-
vertent inclusion of some blood pool region, or some
voxels may only partially be filled by myocardial tissue
over the full slice thickness, which generally exceeds by a
factor of 4-5 the in-plane voxel dimensions (“partial
volume effect”). These partial-volume effects are also
referred to as “spillover” from the blood pool, a term par-
ticularly prevalent in nuclear medicine. In nuclear medi-
cine spillover correction was incorporated by adding to
any model for the myocardial contrast enhancement, a
“spillover” term, which essentially amounts to a scaled
(and time-shifted) arterial input function, with the scaling
factor (and time shift) as variable parameter(s) [25]. Such
an approach has also been tested successfully in MRI stu-
dies of myocardial perfusion [26]. By virtue of the higher
spatial resolution of MRI, it may be preferable in the
future to further optimize the image acquisition to avoid
spillover, rather than trying to estimate any signal admix-
ture from the blood pool, in addition to the tissue perfu-
sion parameters.
A persistently vexing problem in myocardial perfusion
studies has been the appearance of dark rim artifacts at
the endocardial border, when a contrast bolus first enters
the ventricular cavity [27,28]. Several potential mechan-
isms have been proposed to explain this phenomenon,
with arguably the two most likely causes being, the effect
of Gibbs ringing near a sharp and large signal intensity
jump, and magnetic susceptibility effects, which cause
intra-voxel dephasing at the endocardial border. At the
stage of post-processing, the choices to deal with this arti-
fact are limited. One can avoid the region with the dark
rim when the endocardial contour is drawn, by pulling the
contour back towards the epicardial border, but then runs
the risk of missing a perfusion defect limited to the suben-
docardial layer, which is the layer most vulnerable to
ischemia. Alternatively, one can leave out the data points
in the signal intensity curve where the signal intensity
drops significantly below the pre-contrast baseline level.
This is clearly also an unsatisfactory solution, and gener-
ally requires that the signal intensity curve is constrained
by a model to estimate blood flow. With a semi-quantita-
tive, model-independent analysis, such as determination of
the signal-intensity up-slope, the missing data-points may
render it impossible to estimate the semi-quantitative
perfusion parameter.
Units of Perfusion Measurements
Measurements of arterial and myocardial contrast
enhancement do not require any calibration in terms of
absolute units for contrast enhancement. It is sufficient
that they are measured on the same linear scale, irrespec-
tive of whether that scale has absolute or arbitrary units.
The time points for signal intensity readings need to be
recorded in absolute units, for example seconds, relative
to a common reference for all images, such as the start of
the image acquisition. One can then quantify the contrast
enhancement as fraction of the arterial contrast enhance-
ment (ml of arterial input per ml of tissue), and per unit
of time. While the arterial contrast enhancement is typi-
cally measured per unit volume of blood, tissue blood
flow is quoted in mL of arterial input per gram of tissue,
which requires that the unit volume of myocardial tissue
be converted into its mass equivalent, using the specific
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of tissue. Units of ml/min per g of tissue follow naturally
from the procedures for microsphere tissue blood flow
measurements, where the deposition of tracer is mea-
sured per g of tissue sample. The use of microspheres as
reference standard made the units of ml/min per g of
tissue also a natural choice for estimates of myocardial
blood flow with external detection by an imaging device
(MRI, CT, PET, etc.).
Semi-Quantitative Perfusion Measures
Before discussing approaches for quantifying myocardial
blood flow from CMR perfusion studies, brief mention
should be made of semi-quantitative perfusion mea-
sures, which form the basis of perfusion reserve indices.
One such parameter is the so-called “up-slope” [29],
which refers to the slope of the signal-intensity curve
during the early phase of contrast enhancement. More
recently the area under the myocardial signal curve, up
to the time where the first pass peak is observed in the
blood, was used to estimate the perfusion reserve, and
validated against microsphere measurements [30].
Figure 2 illustrates parameters derived from myocardial
signal intensity curves, which have been used as semi-
quantitative markers of tissue perfusion. When mea-
sured from CMR “first pass” studies, the up-slope para-
meter has an approximately linear dependence on blood
flow. It can be used to gauge the relative variation of
blood flow within the LV wall during a given hemody-
namic state. But like nearly all parameters derived from
signal intensity curves, it depends on the shape of the
arterial input, and therefore also on the hemodynamic
conditions. When the up-slope parameter was initially
proposed to assess myocardial perfusion, investigators
normalized it by the up-slope of the signal-intensity in
the LV blood pool [29]. A slightly different form of nor-
malization can be defined, based on the central volume
principle and a linear approximation for the initial arter-
ial input [31]. These empirical adjustments for differ-
ences of the arterial input between hemodynamic states
were used to define a perfusion index, which could be
calculated for rest and stress, and the ratio of the stress
value, divided by the rest value was used as a perfusion
reserve index. The rationale for forming such ratios
goes back to the concept of the coronary flow reserve
(CFR), which corresponds to the ratio of coronary flows
at stress and baseline [32].
One advantage of such a perfusion index is the relative
simplicity of its estimation from the signal intensity
curves. For each perfusion parameter, and with some
form of adjustment for hemodynamic conditions, one
can in principle define a perfusion reserve index. While
these perfusion reserve indices may be proportional to
the coronary flow reserve over some limited range of
CFR, or the perfusion reserve obtained from flows mea-
sured by the microsphere method, they generally each
have specific thresholds to distinguish a hemodynamic
significant stenosis from a coronary artery without flow-
limiting lesions. The semi-quantitative perfusion indices
cannot be compared in magnitude directly to the coron-
ary flow reserve ratio measured in the catheterization
laboratory. A further drawback of any ratio is the poten-
tially confounding effect of the quantity in the denomina-
tor, which purportedly serves the role of “normalization”
[33]. An example is the measurement of the perfusion
reserve in hypertensive patients, where rest perfusion,
which increases in proportion to the rate-pressure pro-
duct, may be abnormally high. Whether the perfusion
reserve in a hypertensive patient is reduced because of
elevated resting blood flow, or an impaired hyperemic
response, or a combination of both cannot be determined
from a ratio, unless the quantities in the numerator and
denominator can be assessed independently. The latter is
only feasible with absolute myocardial blood flows.
Model-based Quantification of Myocardial Blood
Flow
The approaches which can be used for quantifying myo-
cardial blood flow from the observed contrast enhance-
ment can be broadly divided into two categories, which we
label here as model-based, and model-independent. For
model-based approaches one specifies the functional
spaces in myocardial tissue, how tracer moves through
these spaces, and how it traverses permeable barriers
between spaces. A considerable degree of simplification is
necessary to arrive at models that can be used for numeri-
cal calculations and simulations. As commonly used MR
contrast agents, such as Gd-DTPA, are excluded from the
intracellular space one can consider a simplified model
comprising only the vascular and interstitial spaces. Such a
“two-compartment” or “two-space” model [34] can be
used to describe the contrast enhancement, i.e. the change
of signal above its pre-contrast-injection baseline level. In
other words, the background signal, comprising also a
contribution from the intracellular space is subtracted
before model-based-analysis of the contrast enhancement.
Such a baseline correction can also be appropriate for ana-
lyzing the “first pass” enhancement after a previous con-
trast injection, if the background signal has reached an
equilibrium level. Generally, one should wait at least 10
minutes between first pass imaging scans. In our experi-
ence, T1 in the blood pool at approximately 10 minutes
after contrast injection reaches approximately 60% of its
pre-contrast level. This corresponds to approximately
1/10
th to 1/20
th of the peak contrast-enhancement
observed with a 0.03-0.04 mmol/kg bolus of Gd-DTPA,
and therefore amounts to approximately 5-10%, or less, of
the peak contrast enhancement observed during a second
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signal increase in the blood pool. In the myocardium, the
signal intensity level at 10 minutes after contrast injection
is only ~10-20% higher than before contrast injection,
which is a small fraction of the peak myocardial contrast
enhancement during a first pass. After 10 minutes or
longer, the background signal is therefore unlikely to
make a significant contribution to signal saturation effects,
which is arguably the primary concern related to the
contrast residue from a previous injection. Higher contrast
dosages may require longer delays before a repeat
injection.
An important question is whether one wants to treat
the vascular space as spatially lumped compartment
(“well-stirred tank”) with a uniform concentration of
contrast, or whether one accounts for the fact that a
vascular element has a spatial extent and the concentra-
tion of tracer can be higher at the arterial inlet(s) than
further downstream. The latter approach results in a
spatially dependent concentration of tracer or contrast.
Mathematically this translates into the introduction of
(a) spatial variable(s) into the set of (differential) equa-
tions that describe the tissue model, in addition to the
time variable t, that describes the variation of contrast
concentration with time. The compartmental model
without spatial variable(s) on l yc o n s i d e r st h ec h a n g eo f
contrast concentration as a function of time, and is
termed a lumped compartment model. A prototypical
example of a lumped two-compartment model is shown
in Figure 3. The neglect of the spatial concentration gra-
dients can result in an underestimation of the compart-
mental volumes, which can be verified by simulations
where all parameters except the length of an axially-
distributed blood-tissue exchange unit are kept constant.
If the total distribution volume, including the vascular
volume, is kept fixed for fitting of myocardial signal
intensity curves to a model, then a lumped compart-
ment model will result in an overestimate of blood flow,
compared to a spatially distributed model. Using a spa-
tially distributed model instead of a spatially lumped
model can therefore have a significant positive impact
on the accuracy of blood flow estimation.
For an extracellular contrast agent an important contri-
bution to the total observed or measured tissue contrast
concentration comes from the fraction of contrast that
has traversed the capillary barrier and leaked into the
interstitial space [35]. On signal intensity curves from
myocardial perfusion studies the difference becomes
clearly visible in the form of elevated signal intensity after
the first pass of the contrast: contrast has passed into the
interstitial space, and although it will eventually return to
the vascular space and be washed out of the tissue region,
Figure 2 The characteristics of myocardial contrast enhancement. The characteristics of myocardial contrast enhancement have been
assessed in the literature using several parameters, as illustrated in this example, showing the signal intensity changes in the LV blood pool
(arterial input function ℵ AIF), and in an anterior segment of the left ventricle (green circles). The blue line shows the fit to the measured data
with a two-space distributed model. The dashed red line is commonly referred to as the up-slope parameter, and gives the initial rate of
contrast enhancement. It is often normalized by the up-slope of the AIF, as an empirical correction factor to account for hemodynamic changes
between rest and stress. The area under the tissue curve (gray shaded area), up to the location in time where the peak of the AIF is observed,
has been proposed as an alternative parameter to assess perfusion and the perfusion reserve. The myocardial peak signal intensity during the
first pass of the contrast bolus in the LV is arguably the least flow-sensitive parameter, and therefore only used to assess contrast-to-noise, but
not changes or differences in myocardial perfusion.
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f r o mt h et i s s u er e g i o n .F o rt he extracellular contrast
agent one needs to specify the volume of the interstitial
space region, and also specify the rate at which contrast
can traverse the capillary barrier, namely the permeabil-
ity-surface area product (PS). Note, that it is not only the
permeability of the capillary barrier that counts, but also
the total area of this barrier, as a larger capillary surface
area per unit tissue volume will result with constant per-
meability in a higher rate of contrast traversal from the
vascular to the interstitial side. This means that capillary
recruitment during vasodilation results in an increase of
both blood flow and PS [36]. For an extracellular con-
trast agent one can assume that the capillary barrier pas-
sage is driven by the concentration difference between
interstitial and extracellular spaces, and the PS rate con-
stant is the same for either direction of transit. If the pri-
mary goal of the analysis is the quantification of blood
flow, the other model parameters may appear as a nui-
sance. The focus on blood flow often captures only a very
limited view of pathological changes, and effects like lim-
ited capillary recruitment, and a blunted vasodilator
capacity can have a significant effect on PS and vascular
volumes. Unfortunately, it is challenging to quantifying
the permeability surface area product from first pass stu-
dies. A reliable estimate of PS m a yo n l yb ef e a s i b l ew i t h
two contrast injections, using intravascular and extracel-
lular contrast agents respectively.
Identifiability of a model parameter refers to the ability
to measure or detect changes of the model parameter. For
example, it turns out that with an extracellular contrast
agent, the signal intensity curves measured with a CMR
perfusion scan are relatively insensitive to the changes in
vascular volume, because of the leakage of contrast into
the interstitial space - the detected contrast enhancement
corresponds to the effect of contrast in both the vascular
and interstitial spaces. This means that signal intensity
after the first pass primarily reflects the sum of the vascu-
lar and interstitial volume fractions, rather than just the
vascular volume fraction. In the context of a “first pass”
perfusion study, blood flow is a parameter that has a read-
ily identifiable effect on the signal intensity curves, and
this explains in part the reasons why “first pass” perfusion
imaging, independent of modality, has mostly focused on
the quantification of blood flow. For a model-based analy-
sis of myocardial perfusion with an extracellular contrast
agent this means that the vascular and interstitial volume
parameters generally have to be kept at fixed assumed
values, possibly with the constraint that their sum matches
the effective distribution volume.
Central Volume Principle
Model-independent analysis means that one foregoes
specifying a functional model of the tissue structure.
Model-independent analysis is based on the central
volume principle introduced by Kenneth L Zierler in the
the 1960’s [37]. A 2002 review by Zierler offers an inter-
esting historical retrospective on its conceptual develop-
ment and experimental validation [38]. For its derivation
one can start with an observation due to Eugen Fick,
that the rate at which a substance accumulates in a tis-
sue region of interest is given by the difference of con-
centrations of tracer substance flowing into and leaving
the region, multiplied by the flow rate (F): F·(cout - cin)=
dq(t)/dt,w h e r ecin, out denote the concentrations at
(arterial) inlet and (venous) outlet, respectively, q(t) is
the mass of tracer in the region, and dq(t)/dt its rate of
change with time (t). Fick’s principle is simply a state-
ment of mass balance: tracer that has entered the region
and not yet exited remains in the region of interest.
Figure 3 The lumped two-compartment system. a) Schematic diagram of lumped two-compartment model, where it is assumed that
contrast is well-mixed within each compartment at any instant. Blood with tracer or contrast can flow at a rate F into a compartment with
volume fraction v1 and exit on the venous side. The second compartment with volume v2, could represent the interstitial space, and the
exchange of contrast between the two compartments is controlled by a parameter PS, representing the permeability surface area product for
trans-capillary transport of contrast. b) The lumped two compartment system can be represented by a system of coupled linear differential
equations (see appendix A). A solution for a unit impulse of contrast at t = 0, and assuming that there is no contrast in the two two
compartments before this arterial input, was calculated for F = 0.88 ml/min/g and PS = 0.3 ml/min/g, assuming v1 = 0.06 ml/g and v2 = 0.18
ml/g. The red line represents the contrast concentration that would be detected per unit voxel volume, and which is calculated as volume-
fraction-weighted sum of contributions from the vascular space (solid gray line) and the interstitial space (dashed gray line).
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arrive at an expression that relates the tracer amount in
the region, q(t), to its arterial input, in the form of a
convolution integral, which according to Fick’s principle
(in integral form), also has to equal the amount of tracer
that has entered the region, minus the amount that
exited:
qt c t R d F c c d in F in out
t t
() ( ) () [ () () ] =− ⋅ = − ∫ ∫     
0 0
(3)
The function RF(t) represents the q(t) response if an
impulse input of tracer is applied at the region input -
this follows from the integral equation 3, if one replaces
cin with a “Dirac-delta” input function. We also note,
that with such an impulse input (cin (t)=δ(t)) at time
t = 0, there can be no tracer at the output (cout (t =0 )=
0), as this would otherwise require that the tracer or
contrast to traverse region instantaneously, i.e. F ® ∞.
It can be shown then, that RF(t = 0) = F, meaning the
initial amplitude of the impulse response is equal to the
blood flow through the region. This statement can be
generalized to any type of arterial input and it repre-
sents the essence of the Central Volume Principle.
The convolution integral in equation 3 allows one to cal-
culate the q(t) response in a tissue region to a general from
of arterial input cin(t), which can include a recirculating
component of the arterial input. The meaning of the con-
volution integral is illustrated in Figure 4. The Central
Volume Principle allows one to quantify the blood flow
through a region of interest, if the other quantities in
equation 3, namely q(t) and cin(t) can be measured. The
process of extracting RF(t) from the measurements of the
ROI tracer concentration and arterial input concentration
reverses the convolution operation, and is referred to as
deconvolution, a mathematically substantially more chal-
lenging operation, than convolution.
The meaning of the impulse response can be further
elucidated if interpreted as a probability. The value of
RF(t) is normalized for this purpose by its value RF(t =
0) [39]. The normalized impulse response, R(t) = RF(t)/
RF(t = 0), gives for any time t the probability that a tra-
cer molecule still remains in the region of interest at
that time, assuming that it entered at t=0 .I no t h e r
words, the normalized impulse response gives the prob-
ability that the tracer residence time is greater than t.
The complement of this statement is that 1-RF(t),i st h e
probability that the transit time of the tracer is <t. Such
cumulative distribution functions for the transit times or
residence times have to be monotonic functions, which
can be a useful constraint for the estimation of an
impulse response. From the cumulative distribution of
transit times, one can obtain the probability density
function (PDF) for transit times, h(t), by taking the deri-
vative of 1-RF(t).
A quantity often calculated from “first pass” perfusion
studies is the mean transit time. It is defined as the first
moment of the transit time PDF, h(t). For myocardial
perfusion studies with an intravascular contrast agent,
one can use the tissue MTT and estimate of the vascu-
lar volume (V, e.g. from the ratio of steady-state signal
intensities after contrast-enhancement in tissue and
blood) to estimate blood flow:
F
V
MTT
= , (4)
where MTT represents the MTT of tissue, after sub-
tracting the MTT of the first pass of the AIF (i.e. by
excluding the recirculation component). This corollary
of the central volume principle for the special case of an
intravascular tracer is frequently found in the literature
on brain perfusion, because Gd-chelates are confined in
the brain to the vascular bed by the blood brain barrier.
For myocardial perfusion studies, equation 4 only
applies when an intravascular contrast agent is used.
Deconvolution Analysis
The Fourier convolution theorem states that convolu-
tion in the time domain is equivalent to point-wise mul-
tiplication of the Fourier transforms of the two
quantities in the convolution integral. One could there-
fore think of deconvolution in the context of equation 3
as akin to point-wise division of ˆ() q  ,t h eF o u r i e r
transform of q(t),b y ˆ () cin  , the Fourier transform of
the arterial input, to obtain the impulse response
ˆ () RF  in the frequency domain. If ˆ () cin  is a relatively
slowly varying function of time, it will have many loca-
tions at higher frequencies with close to zero, or zero
amplitude. This would mean that point-wise division
ˆ() / ˆ () qc in  is a mathematically unstable approach for
calculating the impulse response from the measured
arterial and myocardial contrast enhancement. Although
the described approach is useless in practice for decon-
volution, the alluded to instability is symptomatic of the
difficulties in performing a deconvolution.
Numerous approaches have been devised to address
the deconvolution problem. Within the context of tra-
cer-kinetic analysis, Axel introduced a useful parametric
representation of the impulse response for the analysis
of brain perfusion studies by computed tomography
[40]. The particular parametric representation of the tis-
s u ei m p u l s er e s p o n s ei n t r o d u c e db yA x e li sk n o w na s
Fermi function, and was chosen based on the insight
that its shape resembles the expected shape of an
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matical representation is:
Rt
A
tk
F()
[exp[( ) / ]
. =
−+  1
The parameter t represents time, and the parameters
μ, k,a n dA, do not have a physiological interpretation,
and should be viewed simply as “shape” parameters. For
example, μ defines the width of the initial plateau,
before the function decays at a rate set by the
parameter k. Only the amplitude of RF(t) for t=0has a
physiological meaning: it corresponds to the blood flow,
according to the Central Volume Theorem. The “shape”
parameters of the Fermi function can be determined with
a non-linear least squares fitting algorithm, such as the
Marquardt Levenberg algorithm. The fitting function is
in this case given by the convolution of the Fermi-func-
tion with the arterial input. In an environment such as
Matlab (The Mathworks, Natick, MA) it is straightfor-
ward to implement this method with a few lines of code.
It is noteworthy that the Fermi function can initially
have approximately constant amplitude before decaying
at an approximately exponential rate. This early plateau
phase means that no, or a negligible amount of tracer has
left the region of interest up to the end of the plateau
duration, and such a plateau is more likely to be observed
for low flows. This can be contrasted with the shape of an
impulse response from a lumped two compartment
model, which consists of a sum of two exponentials that
begin to decay immediately for t >0. The difference is to
be expected for a lumped compartment model, because,
by definition, the contrast agent or tracer is well mixed at
any moment within each compartment. The Fermi
Figure 4 Measured arterial input, impulse responses to arterial input and the tissue curve as a sum of impulse responses.a )F o ra n
illustration of the Central Volume Principle it is useful to consider the arterial input as a sequence of impulses (gray lines with circle at top),
whose amplitudes reproduce the measured arterial input (red line). b) Each of the impulses in the arterial input generates an impulse response
in the tissue, which are all identical, except that each is scaled according to the amplitude of the corresponding impulse in the arterial input,
and each impulse response is shifted so that its start coincides with the location of the arterial input pulse. c) The total tissue response can be
calculated as the sum of the contributions from each impulse response. This sum is the numerical equivalent of the convolution integral of the
arterial input with the impulse response. For deconvolution one attempts to reverse the above process and estimate from the signal curves in
(a) and (b) the form of the impulse response.
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impulse responses of intravascular tracers obtained by
simulations from spatially distributed models. The limita-
tion of the Fermi-function is the fact that it basically
decays like a single exponential, while the most com-
monly used (extracellular) CMR contrast agent also
permeates the interstitial space. For extracellular contrast
agents the impulse response shows an initial fast decay,
related to the vascular transit of contrast, followed by a
slower, long-tailed decay that can be described as the
delayed wash-out of contrast that has crossed the capil-
lary barrier into the interstitial space. Examples of
impulse responses for intravascular and extracellular
contrast agents are shown in Figure 5. Still, the Fermi-
function representation of the impulse response can be
put to good use to estimate myocardial blood flow, by
choosing for the analysis a window that does not exceed
the first pass in the blood pool. During this early phase of
contrast enhancement, any differences between intravas-
cular and extracellular contrast agents are not readily
noticeable, and the analysis provides a good estimate of
myocardial blood flow. The shortest window for analysis
of the contrast enhancement needs to encompass first
pass in the blood pool. Numerical simulations have
shown that this yields accurate estimates of the blood
flow. In practice we set the end point to be at the signal
intensity minimum between first pass and recirculation
peaks in the blood pool. If the time window is extended,
then this results in an increasing bias to underestimate
the blood flow. An example is shown in Figure 6.
The representation of the impulse response shape can be
generalized to properly reproduce also the features of the
impulse response related to the delayed wash-out of con-
trast that has crossed the capillary barrier into the intersti-
tial space. To that end, one can for example use a
representation of the impulse response as a sum of
B-spline components [41]. Nevertheless the algorithmic
procedure to calculate the impulse response with such a
B-spline basis becomes more complicated, and similar
results for flow estimates are still obtained with the Fermi-
function representation, by the sleight of hand described
above.
It lies in the nature of the deconvolution problem that
there is no unique solution for the impulse response,
which is partially why it is considered an “ill-posed” pro-
blem. In fact, the brute force approach of calculating the
impulse response from the Fourier transforms, or other
naive forms of numerical inversion of the deconvolution
operation yield mathematically admissible solutions of the
convolution equation, which nevertheless have to be dis-
missed as unstable, and physiologically unrealistic. Under
most circumstances we are not much concerned about the
exact details of the impulse response, but are primarily
interested in estimating the initial impulse response ampli-
tude, which, by virtue of Zierler’s central volume theorem,
provides an estimate of the blood flow. But there are some
requirements one can impose on the impulse response, e.g.
that it has to be a monotonically decaying function - con-
trast can only leave the region of interest after the initial
arterial impulse input and is not replenished. Furthermore
one can impose some smoothness constraints, as impulse
responses don’t have any sudden jumps in the decay from
their initial amplitude. Such requirements can help to sta-
bilize the deconvolution operation.
The fact that with the deconvolution analysis one does
not need to specify the internal structure of the blood
tissue exchange unit also identifies its main limitation.
At least with an extracellular contrast agent, one can
with the deconvolution analysis determine only the
blood flow, but not other perfusion parameters such as
the vascular volume or the capillary permeability surface
area product. For the latter one has to have some model
to identify these parameters, both in the sense of giving
them a functional meaning within a model of the blood
tissue exchange unit, and also in the sense of being able
to determine stable values from measurements of myo-
cardial contrast enhancement.
Water Exchange
The signal intensity observed during a study of myocar-
dial contrast enhancement originates from the proton
Figure 5 Examples of impulse responses for intravascular and
extracellular contrast agents. Simulated impulse responses for a
spatially distributed model, with myocardial blood flows of 1 (in
blue) and 3 ml/min/g (in red), and for each flow level illustrating
the differences between intravascular (solid line) and extracellular
contrast agent (dashed line). In the latter case the permeability
surface area product was assumed to be 0.6 ml/min/g. Of note is
the initial plateau of the impulse response, which corresponds to
the phase where no detectable amount of tracer has yet left the
blood tissue exchange unit. For the case of an intravascular tracer,
the initial plateau, followed by an exponential decay can be
reproduced well with a Fermi-function as parametric representation
of the impulse response.
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T1 or R1 changes are proportional to the concentration
of contrast agent. This model can become inadequate
when contrast agent is confined to subspaces in the tis-
sue, while water can move between the tissue spaces. In
this latter case the T1 of water protons changes not
only in the subspaces where contrast is introduced
through injection into the blood stream, but also in
spaces that can exchange proton magnetization with
these contrast-permeated subspaces. If the water
exchange is slow in comparison to the difference of the
native relaxation rates (relaxation rates in the absence of
exchange), then one can neglect the effects of water
exchange ("no exchange limit”). At the other extreme
water exchange is so rapid that it can sample the relaxa-
tion environments in the two spaces multiple times dur-
ing the relaxation recovery ("fast exchange limit”). In
this latter case the effective relaxation rate corresponds
to a weighted average of the intrinsic relaxation rates,
with weights determined by the volume fractions of the
two spaces. An example of fast water exchange is the
relaxation of water in blood, which can rapidly move
between blood plasma and red blood cells, because the
dwell time of water in the red blood cells is relatively
short (1-10 ms). In practice this means that the relaxa-
tion rate of water in blood is well described by a single
exponential recovery at a rate that corresponds to the
plasma concentration of contrast, reduced by a factor of
(1-Hct) where Hct represents the blood hematocrit. This
follows from considering the effective T1 of blood in
the fast exchange limit, which is given by the volume-
weighted average of the T1 of water in the blood plasma,
1
1
10 1 11 1
Teff Hct R Hct R R Gd Hct
plasma rbc blood =− ⋅ + ⋅ = =+− ⋅ () ( [ ] ) () r rG d 1[] ,a n dt h e
T1 of water within the erythrocytes.
1
1
10 1 11 1
Teff Hct R Hct R R Gd Hct
plasma rbc blood =− ⋅ + ⋅ = =+− ⋅ () ( [ ] ) () r rG d 1[] (5)
RG d
blood
1 0 ([ ] ) = represents the relaxation rate con-
stant of blood without contrast, r1 is the relaxivity of the
contrast agent, and [Gd] its concentration in plasma.
With fast water exchange the concentration of [Gd] in
plasma is effectively diluted by the (1-Hct) factor.
Within myocardial tissue spaces water exchange (e.g.
across the transcytolemmal barrier) often occurs at a
rate that falls neither into the fast or slow exchange
regimes, and this makes the analysis more tedious, and
a description of the formalism is beyond the scope of
this review [42]. Suffice it to say that the water exchange
necessitates an expansion of the tissue model from a
two to a three space model, to include the intra-cellular
space, even though the contrast agent itself is excluded
from the latter.
The conditions of fast or slow exchange are also
determined by effective relaxation rate, which is a func-
tion of the pulse sequence applied during read-out of
the signal. Assuming that a spoiled gradient echo
sequence is used for read-out with higher flip angle
radio-frequency pulses, then the effect of water
exchange is less noticeable because the radio-frequency
pulses, if applied with short repetition times (TR),
rapidly erase any “memory” of water exchange. A more
formal proof and experimental validation of this can be
Figure 6 Deconvolution of the measured myocardial signal intensity curve (blue circles) with the arterial input (b), was performed
with a Fermi function model of the impulse response (c). Deconvolution of the measured myocardial signal intensity curve (blue circles)
with the arterial input shown in (b), was performed with a Fermi function model of the impulse response as in (c). The time window for the fit
excluded the portion of the signal intensity curve after the first pass in the blood pool (grayed-out). Also the initial transition of the myocardial
signal to a steady state level, before injection of contrast was excluded (grayed out). The best fit to the measured data, shown as solid blue line
in (a) was obtained by non-linear least-squares fitting, using a Marquardt-Levenberg algorithm in the Matlab environment (Mathworks, Natick,
MA). The fitting function is calculated by convolution of the Fermi-function with the measured arterial input. The impulse response shape
corresponding to this best fit is shown in panel (c). The myocardial blood flow is estimated from the initial amplitude of the Fermi impulse
response.
Jerosch-Herold Journal of Cardiovascular Magnetic Resonance 2010, 12:57
http://www.jcmr-online.com/content/12/1/57
Page 12 of 16found in the work of Donahue et al. [43]. More recently
Li et al showed how the combination of short TR and
higher flip angle renders the observed contrast enhance-
ment relatively insensitive to the effects of water
exchange in myocardial tissue [44]. For a relaxation
recovery not disturbed by radio-frequency pulses one
has to use the full water exchange formalism, as the rate
of water exchange falls into a range intermediate
between the “no-exchange” and fast-exchange limits.
Practical Recommendations to Facilitate
Quantification
To counterbalance the partially abstract presentation in
the earlier sections of this review, it may be useful to
include a summary of practical experiences, and possible
recommendations for quantification of myocardial blood
flow. Tools for quantifying perfusion are on the verge of
appearing in cardiac analysis software packages, but they
will for several reasons retain the flavor of a research
tool, that requires technical expertise for its use. Offer-
ing these tools in cardiac image analysis software
packages remains a challenge because of the close link
between acquisition protocols, and post-processing algo-
rithms. As an example: The work-flow in the software
programs may be built on the assumption that signal
intensity in the ventricular cavity or the proximal aorta
can be used to represent the arterial input of contrast.
To what degree that is true, remains under the control
of the user. Furthermore, methods to correct for signal
saturation may require exact knowledge of the protocol
parameters, not all of whic hm a yb ee n c o d e di nt h e
headers of the DICOM images. The user needs to be
acutely aware of the limitation and built-in assumptions
of the quantification algorithms to be used. At this
point one can at least formulate a set of minimal
requirements and recommendations that should be met
if a user wishes to pursue absolute quantification of
myocardial blood flow:
a) The pulse sequence needs to be chosen such that
it allows the recovery of an arterial input function.
For example, any technique where the signal in the
blood pool is suppressed or attenuated by intraven-
tricular flow (echo-planar technique with spin-echo)
would not be suited for the goal of blood flow quan-
tification. Another example is the interleaved
notched saturation preparation [45], which is slice
selective, and therefore produces T1-weighting in
the blood pool that is flow and slice-position depen-
dent. Other advantages of the notched-saturation
technique have led to it being offered as standard
protocol for myocardial perfusion imaging on one
vendor platform.
b )T h ec o n t r a s td o s a g es h o u l db es u f f i c i e n t l yl o wt o
allow recovery of contrast concentration, either by
using a special acquisition technique, such as the
dual-echo technique, or through post-processing,
using calibration curves. For the standard gadopente-
tate dimeglumine agent, this generally means a con-
trast dosage well below 0.1 mmol/kg. If the non-
linearity of contrast-enhancement versus contrast
concentration in the blood pool should not exceed
more than 10-15%, then the contrast dosage may
need to be < 0.03 mmol or less at 1.5 and 3T.
c) For temporal resolution a repetition time corre-
sponding to 1-2 R-to-R intervals at rest, and 1 R-to-
R interval during stress is strongly recommended.
Poor temporal resolution will lead to unacceptably
low accuracy for MBF quantification [34]. Spatial
resolution affects the accuracy of MBF quantification
through partial volume effects, but MBF quantifica-
tion is more forgiving of lower spatial resolution
than temporal resolution, if partial volume effects
are avoided. For adults, an in-plane spatial resolution
< 2.5 mm should be aimed at. Parallel imaging
(SENSE, SMASH, GRAPPA) has become a nearly
standard component of myocardial perfusion ima-
ging, using moderate acceleration factors around 2.
With higher acceleration, the reduction of signal-to-
noise may rapidly become the limiting factor, unless
one uses a sequence technique such as steady-state
free precession. Practical experience with SSFP per-
fusion imaging has shown that its use should be lim-
ited to 1.5 T or lower field strengths, and probably
only with low-dosage contrast bolus [46].
d) New acceleration techniques, such as k-t BLAST
and k-t SENSE [47,48], allow perfusion imaging with
high spatial resolution, but the algorithms applied
for image reconstruction give rise to some degree of
low-pass temporal filtering if high acceleration fac-
tors (~≥8) are used. Such low-pass temporal filter-
ing, will lead to a bias to underestimate flow. The
resolution of this problem will have to await further
advances in these combined spatial-temporal accel-
eration techniques.
e) CMR at 3 Tesla is steadily gaining ground. For
myocardial perfusion imaging with gradient echo
techniques (without steady-state free precession) one
can make an unreserved recommendation for the
higher field strength, because of the concomitant
increase of signal-to-noise compared to 1.5 Tesla.
Although SSFP techniques yield excellent signal-to-
noise ratio at 1.5 Tesla [17,18], there are well-
founded concerns that contrast enhancement with
SSFP can be modulated by confounding factors such
as frequency shifts during bolus passage [46].
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Arguably one of the most serious limitations of quanti-
tative perfusion analysis is the inability to measure the
arterial input accurately and relatively closer to the myo-
cardial region of interest. This has a direct impact on
the accuracy of blood flow estimates. Instead the
enhancement from the contrast bolus is typically mea-
sured in the LV blood pool or the proximal aorta, but
transit through the epicardial vessels is bound to cause
some dispersion of the contrast bolus, which may be
exacerbated by an epicardial stenosis [49]. One is forced
to either neglect this dispersion of the contrast bolus
during transit through the epicardial vessels, or assume
a fixed relative dispersion. A neglect of the dispersion
results in an underestimation of blood flow.
Summary
Cardiac magnetic resonance can be used to quantify
absolute myocardial blood flow with high spatial resolu-
tion, thereby avoiding spill-over of signal from the LV
cavity, and providing an assessment of the transmural
perfusion gradient. The quantification of blood flow is
n o ts i g n i f i c a n t l ym o r et i m ec o n s u m i n gt h a tas e m i -
quantitative analysis, in particular if a deconvolution
method is used for the analysis, requiring minimal user
input. Instead the most time-demanding step continues
to be the segmentation of the images along endo and
epicardial borders. Standardization of the quantitative
analysis still appears to be some time off, as this remains
a field of active investigation, where further optimization
and innovations are still forthcoming at a rate that pre-
cludes a broad consensus and standardization. Despite
its evolving status, quantitative CMR perfusion imaging
has achieved recognized role in studies of coronary phy-
siology and cardiac diseases. Whether it will be adopted
for the clinical workflow remains uncertain at this time.
Appendix A
Example of a two compartment model for
analysis of myocardial perfusion
We consider as an example a spatially-lumped, two
compartment model with flow, F, capillary volume V1
and interstitial volume V2, their respective concentra-
tions, C1 and C2, and an exchange coefficient PS, which
stands for the permeabilty-surface area product. The
equations describing this model are:
V
dc t
dt
F ctc t P S c tc t aif 1
1
12 1
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() () () () =− () +− () (6)
V
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PS c t c t 2
2
12
()
() () =− () (7)
Note that the exchange is passive, as it depends only
on the difference in concentrations between the com-
partments. The tracer concentration in a tissue region
described by this two-compartment model is given by
weighted sum of c1(t) and c2(t), with weights corre-
sponding to the volume fractions of the two compart-
ments:
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It can be shown that the solution of the equations (1)
and (2) to an impulse input is given by the sum of two
exponential functions with coefficients that are propor-
tional to the volumetric flow rate per unit volume.
Obtaining the solution to this set of equations involves
some tedious algebra which we spare the reader. Instead
we included a Mathemetica notebook (Additional file 1),
which can be opened with the Mathematica software
package, or with the free Mathematica player software,
which can be downloaded from http://www.wolfram.
com.
This two-compartment model is used to illustrate the
effects of changes in flow, PS, and compartmental
volumes on the impulse response, and on the tissue
residue curves. The tissue residue curves correspond to
the signal intensity curves that are measured for myo-
cardial regions of interest in a CMR perfusion study.
We also verify that the amplitude of the impulse
response for this lumped two-compartment model cor-
responds to the tissue blood flow, as predicted by Zier-
ler’s central volume theorem.
Additional material
Additional file 1: Two compartment model for analysis of
myocardial perfusion. The solution of the equations (1) and (2) to an
impulse input is given by the sum of two exponential functions with
coefficients that are proportional to the volumetric flow rate per unit
volume. The additional file contains the algebra in a Mathemetica
notebook used to obtain the solution to this set of equations. It can be
opened with the Mathematica software package, or with the free
Mathematica player software, which can be downloaded from http://
www.wolfram.com.
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